Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover s (Q73587689)
Jump to navigation
Jump to search
scientific article published on 01 January 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover s |
scientific article published on 01 January 1997 |
Statements
Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma (English)
F P Maesen
L P Greefhorst
J J Smeets
F D Wald
P J Cornelissen
1 January 1997